European School of Medicinal Chemistry ESMEC
XXXIX Advanced Course of Medicinal Chemistry and Seminar for PhD students
Urbino, Palazzo Battiferri, Via Saffi 42
June 30 – July 4, 2019
The mission of the ESMEC is to provide participants, PhD students and junior researchers from both academia and industry, with the most recent advances in the field of medicinal and organic chemistry, pharmacology, molecular biology and analytical/ structural chemistry. This idea is aimed to reflect the current scenario of medicinal chemistry being a truly transdisciplinary approach, where the advances in knowledge are driven by the medicinal chemist’s ability to translate into new molecular concepts and into novel molecular entities the amount of information created by molecular medicine, pharmacology, molecular biology, systems biology.
For these reasons, the School is directed to participants at a graduated and post-graduated level, in chemistry but also in pharmacology or biology, who are keen to explore the interdisciplinary context of current cutting-edge research in medicinal chemistry.
To achieve these very ambitious goals, the School is organized into thematic sessions, each of them constructed around a series of lectures, followed by practical workshops.
This year the scientific programme includes the following topics:
IMMUNO-ONCOLOGY: SMALL MOLECULES AND BEYOND
Anna MONDINO – IRCCS, San Raffaele Scientific Institute, Milan (I)
Lisa KÖTZNER – Merck KGaA, Darmstadt (D)
Alexander DÖMLING – University of Groningen (NL)
Julio CASTRO-PALOMINO – Palobiofarma, Barcelona (ES)
PHOTOCATALYSIS IN MEDICINAL CHEMISTRY
Paolo MELCHIORRE – ICIQ, Tarragona (ES)
Geraldine MASSON – Institut de Chimie des Substances Naturelles (FR)
Massimo OLIVUCCI – University of Siena (I)
Christopher N. JOHNSON – Astex Pharmaceuticals, Cambridge (UK)
ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY AND DEVELOPMENT
Enzo GROSSI – Villa Santa Maria Foundation, Tavernerio (I)
Jürgen BAJORATH – University of Bonn (D)
Alex TROPSHA – University of North Carolina, Chapel Hill, NC (USA)
Roberta BURSI – InSilicoTrials Technologies, Milan (I)
Market Watch: New Drug Approval in 2018 and Synthetic Strategies
Tiziano BANDIERA – Istituto Italiano di Tecnologia – Genova (I)
Committees
Scientific Committee
Marco Macchia, University of Pisa (Director)
Stefania Butini, University of Siena
Andrea Cavalli, University of Bologna
Paolo Grieco, University of Naples
Antonio Macchiarulo, University of Perugia
Gianluca Papeo, Nerviano Medical Science S.r.l.
Antoni Torrens Jover, Esteve Pharmaceuticals
Tracey Pirali, University of Piemonte Orientale
Gilberto Spadoni, University of Urbino Carlo Bo
Organizing Committee
Annalida Bedini
Lucia Bedini, Treasurer
Andrea Duranti
Simone Lucarini
Michele Mari
Francesca Bartoccini
Organizing Office
Dipartimento di Scienze Biomolecolari
University of Urbino Carlo Bo
Piazza Rinascimento, 6
61029 Urbino (PU) ITALY
tel. +39 0722 304551 / +39 0722 303323
fax. +39 0722 303313
E-mail: lucia.bedini@uniurb.it